Verastem (STU:2VS) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2VS Verastem Inc STU:2VS
39 GF Score
Price €5.07
GF Value €39.87
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Verastem FFO per Share?

FFO per Share only applies to REITs.

STU:2VS
39GF Score
Verastem Inc STU:2VS
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Verastem (STU:2VS) Overvalued in 2026?

Based on GuruFocus' analysis, Verastem stock appears to be undervalued. The current stock price of €5.07 is trading 87.3% below its estimated GF Value™ of €39.87. GuruFocus considers Verastem to be Possible Value Trap.

Key valuation signals for STU:2VS:

  • FFO per Share:
  • GF Value™: €39.87 vs. price of €5.07 (87.3% below fair value)
  • GF Score™: 39/100 with 7 warning signs

No single metric tells the full story. See the STU:2VS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Verastem Business Description

Other Exchanges VSTM:USA0LOV:UK
Address 117 Kendrick Street, Suite 500, Needham, MA, USA, 02494
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
39GF Score

Get the complete analysis for STU:2VS

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.07
Price
€39.87
GF Value